Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

Cited In for PubMed (Select 22286307)


Magnitude and kinetics of multifunctional CD4(+) and CD8β(+) T cells in pigs infected with swine influenza A virus.

Talker SC, Koinig HC, Stadler M, Graage R, Klingler E, Ladinig A, Mair KH, Hammer SE, Weissenböck H, Dürrwald R, Ritzmann M, Saalmüller A, Gerner W.

Vet Res. 2015 May 14;46(1):52. doi: 10.1186/s13567-015-0182-3.


Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.

Bolton KJ, McCaw JM, Brown L, Jackson D, Kedzierska K, McVernon J.

PLoS One. 2015 Mar 26;10(3):e0120138. doi: 10.1371/journal.pone.0120138. eCollection 2015.


Programmed death 1 regulates memory phenotype CD4 T cell accumulation, inhibits expansion of the effector memory phenotype subset and modulates production of effector cytokines.

Charlton JJ, Tsoukatou D, Mamalaki C, Chatzidakis I.

PLoS One. 2015 Mar 24;10(3):e0119200. doi: 10.1371/journal.pone.0119200. eCollection 2015.


Viral infection of human lung macrophages increases PDL1 expression via IFNβ.

Staples KJ, Nicholas B, McKendry RT, Spalluto CM, Wallington JC, Bragg CW, Robinson EC, Martin K, Djukanović R, Wilkinson TM.

PLoS One. 2015 Mar 16;10(3):e0121527. doi: 10.1371/journal.pone.0121527. eCollection 2015.


Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination.

Díez-Domingo J, Baldó JM, Planelles-Catarino MV, Garcés-Sánchez M, Ubeda I, Jubert-Rosich A, Marès J, Garcia-Corbeira P, Moris P, Teko M, Vanden Abeele C, Gillard P.

Influenza Other Respir Viruses. 2015 Mar;9(2):68-77. doi: 10.1111/irv.12295. Epub 2015 Feb 5.


Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans.

Watson JM, Francis JN, Mesens S, Faiman GA, Makin J, Patriarca P, Treanor JJ, Georges B, Bunce CJ.

Virol J. 2015 Feb 3;12(1):13. doi: 10.1186/s12985-015-0240-5.


Immunity to influenza. Preventing infection and regulating disease.

Allen EK, Thomas PG.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):248-51. doi: 10.1164/rccm.201412-2245ED. No abstract available.


Longevity and determinants of protective humoral immunity after pandemic influenza infection.

Sridhar S, Begom S, Hoschler K, Bermingham A, Adamson W, Carman W, Riley S, Lalvani A.

Am J Respir Crit Care Med. 2015 Feb 1;191(3):325-32. doi: 10.1164/rccm.201410-1798OC.


Fast vaccine design and development based on correlates of protection (COPs).

van Els C, Mjaaland S, Næss L, Sarkadi J, Gonczol E, Korsholm KS, Hansen J, de Jonge J, Kersten G, Warner J, Semper A, Kruiswijk C, Oftung F.

Hum Vaccin Immunother. 2014;10(7):1935-48. doi: 10.4161/hv.28639.


Validation of the wild-type influenza A human challenge model H1N1pdMIST: an A(H1N1)pdm09 dose-finding investigational new drug study.

Memoli MJ, Czajkowski L, Reed S, Athota R, Bristol T, Proudfoot K, Fargis S, Stein M, Dunfee RL, Shaw PA, Davey RT, Taubenberger JK.

Clin Infect Dis. 2015 Mar 1;60(5):693-702. doi: 10.1093/cid/ciu924. Epub 2014 Nov 20.


Distinct patterns of B-cell activation and priming by natural influenza virus infection versus inactivated influenza vaccination.

He XS, Holmes TH, Sanyal M, Albrecht RA, García-Sastre A, Dekker CL, Davis MM, Greenberg HB.

J Infect Dis. 2015 Apr 1;211(7):1051-9. doi: 10.1093/infdis/jiu580. Epub 2014 Oct 21.


Influenza vaccines: a moving interdisciplinary field.

Schotsaert M, García-Sastre A.

Viruses. 2014 Oct 9;6(10):3809-26. doi: 10.3390/v6103809.


Immunologic characterization of a rhesus macaque H1N1 challenge model for candidate influenza virus vaccine assessment.

Skinner JA, Zurawski SM, Sugimoto C, Vinet-Oliphant H, Vinod P, Xue Y, Russell-Lodrigue K, Albrecht RA, García-Sastre A, Salazar AM, Roy CJ, Kuroda MJ, Oh S, Zurawski G.

Clin Vaccine Immunol. 2014 Dec;21(12):1668-80. doi: 10.1128/CVI.00547-14. Epub 2014 Oct 8.


The potential for a controlled human infection platform in Singapore.

Balasingam S, Horby P, Wilder-Smith A.

Singapore Med J. 2014 Sep;55(9):456-61.


Sortase A induces Th17-mediated and antibody-independent immunity to heterologous serotypes of group A streptococci.

Fan X, Wang X, Li N, Cui H, Hou B, Gao B, Cleary PP, Wang B.

PLoS One. 2014 Sep 18;9(9):e107638. doi: 10.1371/journal.pone.0107638. eCollection 2014.


Asymptomatic HIV-infected individuals on antiretroviral therapy exhibit impaired lung CD4(+) T-cell responses to mycobacteria.

Jambo KC, Banda DH, Afran L, Kankwatira AM, Malamba RD, Allain TJ, Gordon SB, Heyderman RS, Russell DG, Mwandumba HC.

Am J Respir Crit Care Med. 2014 Oct 15;190(8):938-47. doi: 10.1164/rccm.201405-0864OC.


T-cell-mediated cross-strain protective immunity elicited by prime-boost vaccination with a live attenuated influenza vaccine.

Li J, Arévalo MT, Chen Y, Chen S, Zeng M.

Int J Infect Dis. 2014 Oct;27:37-43. doi: 10.1016/j.ijid.2014.05.016. Epub 2014 Aug 27.


Dynamics of lung defense in pneumonia: resistance, resilience, and remodeling.

Quinton LJ, Mizgerd JP.

Annu Rev Physiol. 2015;77:407-30. doi: 10.1146/annurev-physiol-021014-071937. Epub 2014 Aug 13.


Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.

Sanchez MV, Ebensen T, Schulze K, Cargnelutti D, Blazejewska P, Scodeller EA, Guzmán CA.

PLoS One. 2014 Aug 20;9(8):e104824. doi: 10.1371/journal.pone.0104824. eCollection 2014.


Immunodominant CD4+ T-cell responses to influenza A virus in healthy individuals focus on matrix 1 and nucleoprotein.

Chen L, Zanker D, Xiao K, Wu C, Zou Q, Chen W.

J Virol. 2014 Oct;88(20):11760-73. doi: 10.1128/JVI.01631-14. Epub 2014 Jul 30.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk